ATAI.D

AtaiBeckley Inc.

Healthcare · Biotechnology

$212.11 sample

+0.97 (+0.46%) 1D

Market cap

$533.7B

Price as of

2026-10-24

Latest filing

8-K · 2026-10-06

Alerts

8

Price$212.11 +19.92% 3M daily closessample

214.29174.79

2026-07-282026-08-192026-09-102026-10-012026-10-23

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 21INSInsider sell: Chief Executive Officer
Oct 15INSInsider sell: Chief Executive Officer
Oct 06SEC10-Q filed
Oct 01INSInsider sell: General Counsel
Sep 23SECDEF 14A filed
Sep 16INSInsider sell: Director
Sep 10INSInsider sell: Chief Executive Officer
Sep 02INSInsider sell: 10% owner

Sign up to see the real ATAI.D record →

Company facts

SEC EDGAR registration

Name: AtaiBeckley Inc.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: +36sample, -100 to +100
Reporting currency: USD

Who is positioning in ATAI.D

sample

Insiders: 18 insider transactions over 90 days, net selling, $741.9M
Congress: 4 members traded over 90 days
Institutions · 13F: 24 funds hold $3.2B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$34.2B +17.3% y/y

Q4 2024Q3 2026

Inventory$20.7B +15.7% y/y

Q4 2024Q3 2026

Accounts receivable$15.2B +8.7% y/y

Q4 2024Q3 2026

Total debt$38.6B +13.2% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $385.5B -9.0% 3M
Sample peer B: $152.4B +5.2% 3M
Sample peer C: $89.3B +12.9% 3M
Sample peer D: $115.0B +14.6% 3M
Sample peer E: $307.3B +12.0% 3M